Respiratory diseases don’t wait for better financial circumstances. Missing inhaler doses because of cost leads to symptom escalation and emergency interventions.
At The Rx Advocates, we specialize in connecting patients to manufacturer Patient Assistance Programs (PAPs). These programs replace unpredictable prescription expenses with set monthly fees, allowing you to maintain treatment without financial panic.
Medically Reviewed by Dr. Conor Sheehy, PharmD, BCPS
Manufacturers fund these programs specifically for individuals facing affordability barriers with respiratory medications. Unlike coupons that expire or have refill limits, the Airsupra program provides sustained access to your inhaler.
Our role? We connect you to these manufacturer-run initiatives. This means gathering your paperwork, coordinating with your pulmonary specialist, and submitting everything to the pharmaceutical companies operating these programs. We maintain contact throughout to track your application’s progress. After approval, refills get coordinated automatically to prevent treatment gaps.
We’ve built relationships spanning 100+ pharmaceutical companies, giving access to programs covering 800+ FDA-approved medications. These partnerships allow us to help patients access everything from respiratory inhalers to diabetes medications, all through manufacturer-sponsored assistance programs.
Meeting income requirements doesn’t guarantee acceptance. Manufacturers review individually. But we ensure your application is complete and accurate before submission, maximizing approval chances.
Income and residency determine eligibility. We assess your finances against each manufacturer’s specific requirements to identify whether you meet their standards.
Standard thresholds:
Each company sets its own rules. Airsupra's program may differ from other respiratory medication programs. Some manufacturers accept higher income levels. Contact us to verify your specific situation against current criteria and see if you qualify.
The monthly service fee depends on the number
of medications you take. For example:
In addition to our monthly service fee, we charge a one-time enrollment fee of $35.
Our service is month-to-month, so if you’re not happy with it, you may cancel at any time
We’re not coupons. We’re not insurance. We’re not discount cards. We build pathways to pharmaceutical company programs that make medications affordable.
Here’s how it works: We partner with you and your medical team to compile applications. We submit them to manufacturers. We track progress through approval. We coordinate refills after acceptance. The entire process gets managed by our team so you can focus on breathing easier instead of managing paperwork.
Cost structure: $35 one-time enrollment, then monthly fees based on prescription count. After manufacturer approval, medications ship at no additional charge. Our service fee is your only recurring expense, and it doesn’t fluctuate with retail prices. Whether Airsupra’s retail cost is $500 or $600, your monthly fee stays the same.
Coupons provide temporary relief. Patient assistance programs provide sustained solutions. For chronic respiratory conditions requiring years of treatment, this difference matters significantly.
$80 / Month
30-Day Supply
Last Updated: September 29, 2025. Actual retail prices may vary by pharmacy and location
With The Rx Advocates, patients pay a fixed monthly service fee, which depends on the number of medications covered.
Importantly, there are no hidden fees, and prices remain consistent even if retail costs fluctuate.
Pricing varies by:
Income limits: $40,000 (singles), $60,000 (couples), $100,000 (families). Most programs target uninsured or underinsured patients. We’ll verify your eligibility and handle all paperwork, from initial application through final approval.
We manage everything. Eligibility verification. Document preparation. Provider coordination. Manufacturer submission. After approval, automatic deliveries ensure your inhaler arrives without reapplication. Most people either don’t know these programs exist or quit because applications are too complicated. We solve both problems by simplifying the entire process.
Airsupra combines albuterol (bronchodilator) with budesonide (corticosteroid) for asthma and COPD treatment.
How it works: Fast symptom relief plus inflammation reduction. Albuterol opens airways quickly for immediate relief. Budesonide addresses underlying inflammation for longer-term control. This dual-action approach makes it effective for managing chronic respiratory conditions.
Format: Inhalation aerosol (90 mcg-80 mcg per inhalation), 10.7 gram supply. Prescribed as part of comprehensive respiratory treatment plans.
Side effects:
Important: Not for acute rescue during severe attacks. Requires consistent use for effectiveness. Rinse mouth after inhalation to prevent oral thrush. Report all medications to your doctor due to interaction potential. Regular monitoring needed to assess treatment effectiveness and adjust dosing.
Respiratory health requires consistent medication. Skipping doses because of cost concerns leads to declining lung function, increased exacerbation risk, and potential hospitalizations. The long-term health consequences far outweigh the short-term savings from missed doses.
We handle the patient assistance application process from start to finish. After approval, inhalers arrive monthly at a predictable price that won’t suddenly spike.
Ready to afford respiratory treatment without sacrificing other necessities? Contact us to check eligibility and begin enrollment.